Literature DB >> 24145845

When policy gets it right: variability in u.s. Hospitals' diagnosis of ventilator-associated pneumonia*.

Jennifer P Stevens1, Bartlomiej Kachniarz, Sharon B Wright, Jean Gillis, Daniel Talmor, Peter Clardy, Michael D Howell.   

Abstract

OBJECTIVE: The Centers for Disease Control has recently proposed a major change in how ventilator-associated pneumonia is defined. This has profound implications for public reporting, reimbursement, and accountability measures for ICUs. We sought to provide evidence for or against this change by quantifying limitations of the national definition of ventilator-associated pneumonia that was in place until January 2013, particularly with regard to comparisons between, and ranking of, hospitals and ICUs.
DESIGN: A prospective survey of a nationally representative group of 43 hospitals, randomly selected from the American Hospital Association Guide (2009). Subjects classified six standardized vignettes of possible cases of ventilator-associated pneumonia as pneumonia or no pneumonia.
SUBJECTS: Individuals responsible for ventilator-associated pneumonia surveillance at 43 U.S. hospitals.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We measured the proportion of standardized cases classified as ventilator-associated pneumonia. Of 138 hospitals consented, 61 partially completed the survey and 43 fully completed the survey (response rate 44% and 31%, respectively). Agreement among hospitals about classification of cases as ventilator-associated pneumonia/not ventilator-associated pneumonia was nearly random (Fleiss κ 0.13). Some hospitals rated 0% of cases as having pneumonia; others classified 100% as having pneumonia (median, 50%; interquartile range, 33-66%). Although region of the country did not predict case assignment, respondents who described their region as "rural" were more likely to judge a case to be pneumonia than respondents elsewhere (relative risk, 1.25, Kruskal-Wallis chi-square, p = 0.03).
CONCLUSIONS: In this nationally representative study of hospitals, assignment of ventilator-associated pneumonia is extremely variable, enough to render comparisons between hospitals worthless, even when standardized cases eliminate variability in clinical data abstraction. The magnitude of this variability highlights the limitations of using poorly performing surveillance definitions as methods of hospital evaluation and comparison, and our study provides very strong support for moving to a more objective definition of ventilator-associated complications.

Entities:  

Mesh:

Year:  2014        PMID: 24145845     DOI: 10.1097/CCM.0b013e3182a66903

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  28 in total

1.  What's new in ventilator-associated pneumonia?

Authors:  Jordi Rello; Jordi Riera; Ricardo Serrano
Journal:  Intensive Care Med       Date:  2015-06-11       Impact factor: 17.440

Review 2.  State-mandated reporting of health care-associated infections in the United States: trends over time.

Authors:  Carolyn T A Herzig; Julie Reagan; Monika Pogorzelska-Maziarz; Divya Srinath; Patricia W Stone
Journal:  Am J Med Qual       Date:  2014-06-20       Impact factor: 1.852

3.  Ventilator-associated conditions versus ventilator-associated pneumonia: different by design.

Authors:  Michael Klompas
Journal:  Curr Infect Dis Rep       Date:  2014-10       Impact factor: 3.725

4.  Assessment of the accuracy and consistency in the application of standardized surveillance definitions: A summary of the American Journal of Infection Control and National Healthcare Safety Network case studies, 2010-2016.

Authors:  Marc-Oliver Wright; Katherine Allen-Bridson; Joan N Hebden
Journal:  Am J Infect Control       Date:  2017-06-01       Impact factor: 2.918

5.  Prevalence, Clinical Characteristics, and Outcomes of Sepsis Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Versus Other Pathogens in Hospitalized Patients With COVID-19.

Authors:  Claire N Shappell; Michael Klompas; Sanjat Kanjilal; Christina Chan; Chanu Rhee
Journal:  Crit Care Explor       Date:  2022-05-13

Review 6.  Prone position for acute respiratory failure in adults.

Authors:  Roxanna Bloomfield; David W Noble; Alexis Sudlow
Journal:  Cochrane Database Syst Rev       Date:  2015-11-13

Review 7.  Improving ventilator-associated event surveillance in the National Healthcare Safety Network and addressing knowledge gaps: update and review.

Authors:  Shelley S Magill; Barry Rhodes; Michael Klompas
Journal:  Curr Opin Infect Dis       Date:  2014-08       Impact factor: 4.915

8.  Comparison of the New Adult Ventilator-Associated Event Criteria to the Centers for Disease Control and Prevention Pediatric Ventilator-Associated Pneumonia Definition (PNU2) in a Population of Pediatric Traumatic Brain Injury Patients.

Authors:  Meghan M Cirulis; Mitchell T Hamele; Chris R Stockmann; Tellen D Bennett; Susan L Bratton
Journal:  Pediatr Crit Care Med       Date:  2016-02       Impact factor: 3.624

9.  Variability in determining sepsis time zero and bundle compliance rates for the centers for medicare and medicaid services SEP-1 measure.

Authors:  Chanu Rhee; Sarah R Brown; Travis M Jones; Cara O'Brien; Anupam Pande; Yasir Hamad; Amy L Bulger; Kathleen A Tobin; Anthony F Massaro; Deverick J Anderson; David K Warren; Michael Klompas
Journal:  Infect Control Hosp Epidemiol       Date:  2018-06-22       Impact factor: 3.254

10.  The preventability of ventilator-associated events. The CDC Prevention Epicenters Wake Up and Breathe Collaborative.

Authors:  Michael Klompas; Deverick Anderson; William Trick; Hilary Babcock; Meeta Prasad Kerlin; Lingling Li; Ronda Sinkowitz-Cochran; E Wesley Ely; John Jernigan; Shelley Magill; Rosie Lyles; Caroline O'Neil; Barrett T Kitch; Ellen Arrington; Michele C Balas; Ken Kleinman; Christina Bruce; Julie Lankiewicz; Michael V Murphy; Christopher E Cox; Ebbing Lautenbach; Daniel Sexton; Victoria Fraser; Robert A Weinstein; Richard Platt
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 30.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.